NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
Nutex Health (NASDAQ: NUTX) has announced the rescheduling of its fourth quarter and full year 2024 financial results release and conference call. The company has moved the earnings release from March 27 to March 31, 2025 (after market close), with the conference call now scheduled for April 1, 2025 at 10:30 a.m. ET.
The company stated it is utilizing the full time allowed by regulations to complete its year-end reporting process. Investors can access the conference call through the dial-in numbers 1-877-407-9208 or 1-201-493-6784, with a recording to be made available on the company's website for those unable to attend live.
Nutex Health (NASDAQ: NUTX) ha annunciato il riprogrammazione della pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024 e della relativa conference call. L'azienda ha spostato la pubblicazione degli utili dal 27 marzo al 31 marzo 2025 (dopo la chiusura del mercato), con la conference call ora programmata per 1 aprile 2025 alle 10:30 ET.
L'azienda ha dichiarato di utilizzare tutto il tempo consentito dalle normative per completare il processo di reporting di fine anno. Gli investitori possono accedere alla conference call tramite i numeri di accesso 1-877-407-9208 o 1-201-493-6784, con una registrazione che sarà resa disponibile sul sito web dell'azienda per coloro che non possono partecipare dal vivo.
Nutex Health (NASDAQ: NUTX) ha anunciado la reprogramación de la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024, así como de la conferencia telefónica. La compañía ha movido la publicación de ganancias del 27 de marzo al 31 de marzo de 2025 (después del cierre del mercado), con la conferencia telefónica ahora programada para el 1 de abril de 2025 a las 10:30 a.m. ET.
La compañía declaró que está utilizando todo el tiempo permitido por las regulaciones para completar su proceso de reporte de fin de año. Los inversores pueden acceder a la conferencia telefónica a través de los números de marcación 1-877-407-9208 o 1-201-493-6784, y se pondrá a disposición una grabación en el sitio web de la compañía para aquellos que no puedan asistir en vivo.
Nutex Health (NASDAQ: NUTX)는 2024년 4분기 및 연간 재무 결과 발표 및 컨퍼런스 콜 일정 변경을 발표했습니다. 회사는 수익 발표를 3월 27일에서 2025년 3월 31일로 변경했으며(시장 종료 후), 컨퍼런스 콜은 이제 2025년 4월 1일 오전 10시 30분 ET로 예정되어 있습니다.
회사는 연말 보고 프로세스를 완료하기 위해 규정이 허용하는 전체 시간을 활용하고 있다고 밝혔습니다. 투자자는 1-877-407-9208 또는 1-201-493-6784의 전화번호를 통해 컨퍼런스 콜에 접속할 수 있으며, 생방송에 참석할 수 없는 경우 회사 웹사이트에서 녹음된 내용을 확인할 수 있습니다.
Nutex Health (NASDAQ: NUTX) a annoncé le report de la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 ainsi que de la conférence téléphonique. La société a déplacé la publication des résultats du 27 mars au 31 mars 2025 (après la fermeture du marché), la conférence téléphonique étant désormais prévue pour le 1er avril 2025 à 10h30 ET.
La société a déclaré qu'elle utilise tout le temps autorisé par la réglementation pour finaliser son processus de reporting de fin d'année. Les investisseurs peuvent accéder à la conférence téléphonique via les numéros d'appel 1-877-407-9208 ou 1-201-493-6784, et un enregistrement sera disponible sur le site web de l'entreprise pour ceux qui ne peuvent pas assister en direct.
Nutex Health (NASDAQ: NUTX) hat die Neuansetzung der Veröffentlichung seiner Finanzresultate für das vierte Quartal und das gesamte Jahr 2024 sowie der Konferenzschaltung bekannt gegeben. Das Unternehmen hat die Veröffentlichung der Ergebnisse vom 27. März auf den 31. März 2025 (nach Börsenschluss) verschoben, mit der Konferenzschaltung, die nun für den 1. April 2025 um 10:30 Uhr ET angesetzt ist.
Das Unternehmen gab an, dass es die volle Zeit, die die Vorschriften erlauben, nutzt, um seinen Jahresabschlussbericht abzuschließen. Investoren können über die Einwahlnummern 1-877-407-9208 oder 1-201-493-6784 auf die Konferenzschaltung zugreifen, und eine Aufzeichnung wird auf der Unternehmenswebsite für diejenigen verfügbar sein, die nicht live teilnehmen können.
- None.
- Delayed earnings release indicates potential complications in financial reporting process
Participant Listening: 1-877-407-9208 or 1-201-493-6784
Participant Link: https://viavid.webcasts.com/starthere.jsp?ei=1706653&tp_key=5e3e4c2f67
To access the call, please dial in approximately five minutes before start time. Those who are unable to attend the live conference call may access the recording on the Company's website.
About Nutex Health Inc.
Headquartered in
- Hospital Division: Owns, develops and operates innovative healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division currently owns and operates 24 facilities across 11 states.
- Population Health Management Division: Owns and operates provider networks such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), Nutex Health provides management, administrative, and other support services to its affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, June 30, 2024 and September 30, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-reschedules-earnings-release-and-conference-call-302413762.html
SOURCE Nutex Health, Inc.
FAQ
When will Nutex Health (NUTX) release its Q4 and FY 2024 earnings?
What is the new date and time for NUTX's Q4 2024 earnings conference call?
Why did NUTX reschedule its Q4 2024 earnings release?
How can investors access NUTX's Q4 2024 earnings call?
